March 14, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bridge Investment Group Holdings Inc. (“Bridge” or “the Company”) (NYSE: BRDG). Investors who purchased Bridge securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Bridge… read more
March 14, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CI&T Inc. (“CI&T” or “the Company”) (NYSE: CINT). Investors who purchased CI&T securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether CI&T has violated federal… read more
March 14, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dollar Tree, Inc. (“Dollar Tree” or “the Company”) (NASDAQ: DLTR). Investors who purchased Dollar Tree securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Dollar… read more
March 14, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Spruce Biosciences, Inc. (“Spruce” or “the Company”) (NASDAQ: SPRB). Investors who purchased Spruce securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Spruce has violated… read more
March 13, 2024 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against HireRight Holdings Corporation (“HireRight” or “the Company”) (NYSE: HRT) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants… read more
March 7, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of WW International Inc. (“Weight Watchers” or “the Company”) (NASDAQ: WW). Investors who purchased Weight Watchers securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Weight… read more
March 7, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Community Health Systems, Inc. (“Community Health” or “the Company”) (NYSE: CYH). Investors who purchased Community Health securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
March 6, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Entravision Communications Corp. (“Entravision” or “the Company”) (NYSE: EVC). Investors who purchased Entravision securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Entravision has violated… read more
March 5, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of JBS S.A. (“JBS” or “the Company”) (OTC: JBSAY). Investors who purchased JBS securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether JBS has violated federal… read more
February 29, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of General American Investors, Inc. (“General American Investors” or “the Company”) (NYSE: GAM). Investors who purchased General American Investors securities prior to February 9, 2024, and continue to hold to the present,… read more
February 29, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II (“KIND” or “the Company”) (NYSE: KIND). Investors who purchased KIND securities prior to November 2, 2021, and continue to hold to the… read more
February 29, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alignment Healthcare, Inc. (“Alignment” or “the Company”) (NASDAQ: ALHC). Investors who purchased Alignment securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alignment has violated… read more
February 28, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of R1 RCM Inc. (“R1 RCM” or “the Company”) (NASDAQ: RCM). Investors who purchased R1 RCM securities are encouraged to obtain additional information and assist the investigation. Investigation Details: The investigation concerns… read more
February 28, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of World Acceptance Corporation (“WAC” or “the Company”) (NASDAQ: WRLD). Investors who purchased WAC securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether WAC has violated… read more
February 27, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Agiliti Inc. (“Agiliti” or “the Company”) (NYSE: AGTI). Investors who purchased Agiliti securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Agiliti has violated federal… read more
February 25, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of VIZIO Holding Corp. (“VIZIO” or “the Company”) (NYSE: VZIO). Investors who purchased VIZIO securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether VIZIO has violated… read more
February 23, 2024 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Palo Alto Networks, Inc. (“Palo Alto” or “the Company”) (NYSE: PANW) and certain of its officers. Class Definition: This lawsuit seeks to recover damages… read more
February 23, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AirSculpt Technologies, Inc. (“AirSculpt” or “the Company”) (NASDAQ: AIRS). Investors who purchased AirSculpt securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether AirSculpt has violated… read more
February 23, 2024 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rivian Automotive, Inc. (“Rivian” or “the Company”) (NASDAQ: RIVN) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants… read more
February 22, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of HSBC Holdings plc (“HSBC” or “the Company”) (NYSE: HSBC). Investors who purchased HSBC securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether HSBC has violated… read more
February 22, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lloyds Banking Group Plc (“Lloyds” or “the Company”) (NYSE: LYG). Investors who purchased Lloyds securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Lloyds has… read more
February 22, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sibanye Stillwater Limited (“Sibanye Stillwater” or “the Company”) (NYSE: SBSW). Investors who purchased Sibanye Stillwater securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sibanye… read more
February 21, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RAPT Therapeutics, Inc. (“RAPT” or “the Company”) (NASDAQ: RAPT). Investors who purchased RAPT securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether RAPT has violated… read more
February 15, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gryphon Digital Mining, Inc. (“Gryphon” or “the Company”) (NASDAQ: GRYP). Investors who purchased Gryphon securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Gryphon has… read more
February 14, 2024 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against InMode Ltd. (“InMode” or “the Company”) (NASDAQ: INMD) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for… read more
February 13, 2024 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Exscientia p.l.c. (“Exscientia” or “the Company”) (NASDAQ: EXAI) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for… read more
February 12, 2024 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lantronix, Inc. (“Lantronix” or “the Company”) (NASDAQ: LTRX) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for… read more
February 7, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Qualys, Inc. (“Qualys” or “the Company”) (NASDAQ: QLYS). Investors who purchased Qualys securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Qualys has violated federal… read more
February 7, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Brainstorm Cell Therapeutics Inc. (“Brainstorm Cell” or “the Company”) (NASDAQ: BCLI). Investors who purchased Brainstorm Cell securities prior to August 15, 2022, and continue to hold to the present, are encouraged… read more
February 7, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cerence Inc. (“Cerence” or “the Company”) (NASDAQ: CRNC). Investors who purchased Cerence securities prior to November 16, 2020, and continue to hold to the present, are encouraged to obtain additional information… read more